Search
A protein in the body that protects against viruses can also cause cancer-related mutations.
Now in its 14th year, Cycle for Survival has raised more than $260 million for research on rare cancers.
Memorial Sloan Kettering plastic and reconstructive surgeon Michelle Coriddi describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.
Memorial Sloan Kettering Cancer Center (MSK) today announced it has received a new grant from the National Cancer institute (NCI), part of the National Institutes of Health, under the umbrella of the Cancer Moonshot, to create the MATCHES (Making Telehealth Delivery of Cancer Care at Home Effective and Safe) Telehealth Research Center at MSK, a first of its kind.
A new project called the BRCA Exchange is sharing data about BRCA mutations and what they actually mean for cancer risk.
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.
Researchers at MSK have been at the forefront of developing new treatments for advanced melanoma for many years. Learn more about the latest therapies.
Learn from neurosurgeon Viviane Tabar about the standard treatment for glioblastoma, which involves surgery, chemotherapy, and radiation.
State-of-the-art facility will be reduced by 76 feet while continuing to meet increasing demand for cancer care.
Learn about the latest advances in lung cancer treatment at MSK.